Гемостаз и тромбозы

НОВАЯ СТАТЬЯ

Correction: Proteomic screening identifies PF4/Cxcl4 as a critical driver of myelofibrosis.

У данной статьи нет абстракта.

DOI: 10.1038/s41375-025-02587-6
Capitanio D, Calledda FR, Abbonante V, Cattaneo D, Moriggi M, Bartalucci N, Bucelli C, Tosi D, Gianelli U, Vannucchi AM, Iurlo A, Gelfi C, Balduini A, Malara A
Leukemia, 2025-04-03
НОВАЯ СТАТЬЯ

Factor XI inhibitors for the prevention and treatment of venous and arterial thromboembolism.

Therapeutic anticoagulation is essential to prevent and treat venous and arterial thromboembolism...

DOI: 10.1038/s41569-025-01144-z
Capodanno D, Alexander JH, Bahit MC, Eikelboom JW, Gibson CM, Goodman SG, Kunadian V, Lip GYH, Lopes RD, Mehran R, Mehta SR, Patel MR, Piccini JP, Rao SV, Ruff CT, Steg PG, Weitz JI, Angiolillo DJ
Nature reviews. Cardiology, 2025-04-03
НОВАЯ СТАТЬЯ

Extended Reduced-Dose Apixaban for Cancer-Associated Venous Thromboembolism.

Extended anticoagulation with reduced-dose apixaban was noninferior to full-dose apixaban for the prevention of recurrent venous thromboembolism in patients with active cancer. The reduced dose led to a lower incidence of clinically relevant bleeding complications than the full dose. (Funded by the Bristol-Myers Squibb-Pfizer Alliance; API-CAT ClinicalTrials.gov number, NCT03692065.).

DOI: 10.1056/NEJMoa2416112
Mahé I, Carrier M, Mayeur D, Chidiac J, Vicaut E, Falvo N, Sanchez O, Grange C, Monreal M, López-Núñez JJ, Otero-Candelera R, Le Gal G, Yeo E, Righini M, Robert-Ebadi H, Huisman MV, Klok FA, Westerweel P, Agnelli G, Becattini C, Bamias A, Syrigos K,
The New England journal of medicine, 2025-04-03
НОВАЯ СТАТЬЯ

Five-decades of successive establishment of hemophilia care in Thailand.

Hemophilia care in Thailand constitutes the real-world experience passing from generation to generation for five decades using our limited resources efficiently.

DOI: 10.1080/17474086.2025.2486378
Chuansumrit A, Sriphaisal T, Krutvecho T, Sirachainan N, Kitpoka P, Pitakcharoen M, Jaovisidha S, Panburana P, Suwannuraks M, Sri-Udomporn N, Kijkunasathian C, Nateserinilkul R, Pongtanakul B, Traivaree C, Komvilaisak P, Sosothikul D, Lektrakul Y, Nu
Expert review of hematology, 2025-04-03
НОВАЯ СТАТЬЯ

Long-Term Impact of Early Subclinical Leaflet Thrombosis After Transcatheter Aortic Valve Implantation.

HALT within 30 days was not associated with clinical outcomes or hemodynamic performance during long-term follow-up.

DOI: 10.1002/ccd.31435
Iwata J, Hayashida K, Arita R, Moriizumi T, Kajino A, Sakata S, Ryuzaki T, Shinada K, Tsuruta H, Yamada Y, Kato J, Takahashi T, Yamazaki M, Jinzaki M, Shimizu H, Ieda M
Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions, 2025-04-03
НОВАЯ СТАТЬЯ

Cluster analysis of hepatocellular carcinoma prognosis using preoperative alpha-fetoprotein and des-gamma-carboxy prothrombin levels: a multi-institutional study.

Our study introduces tumor marker clustering as a novel analytical approach, providing a nuanced understanding of AFP and DCP's combined utility in predicting prognosis and recurrence. Our findings highlight the independent and complementary roles of these biomarkers, particularly in NBNC-related HCC and in cases with impaired liver function. AFP and DCP remain crucial tools for recurrence risk assessment, guiding personalized management strategies, such as surveillance, neoadjuvant therapies, and tailored postoperative interventions.

DOI: 10.1016/j.gassur.2025.101980
Saegusa Y, Imaoka Y, Ohira M, Kobayashi T, Honmyo N, Hamaoka M, Onoe T, Takei D, Oishi K, Abe T, Nakayama T, Akabane M, Sasaki K, Ohdan H,
Journal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract, 2025-04-03

Fetal umbilical vein thrombosis associated with fetal bartter syndrome: an unusual case report and literature review.

This case highlights a suspected instance of umbilical vein thrombosis and polyhydramnios potentially linked to fetal Bartter syndrome. Currently, the causes of umbilical vein thrombosis primarily focus on abnormalities in umbilical cord structure or mechanical injury to the cord, with few cases involving fetal genetic conditions. The purpose of this report is to enhance medical professionals' understanding of Bartter syndrome and to consider it as a possible cause of fetal umbilical vein thrombosis and polyhydramnios. Further research should explore the link between fetal Bartter syndrome, umbilical vein thrombosis, and polyhydramnios. Additionally, strengthening case collection and analysis will help accumulate experience, optimize management strategies, and improve maternal and fetal outcomes.

DOI: 10.1186/s12884-025-07496-1
Zhao J, Xing A, Jia J
BMC pregnancy and childbirth, 2025-04-01

A Descriptive 5-Year Analysis of the Demographics and Therapies for Patients With Immune Thrombotic Thrombocytopenic Purpura in the USA: A Multicenter Study of 390 Disease Episodes From 2017 to 2021.

Immune thrombotic thrombocytopenic purpura (iTTP) is characterized by microangiopathic hemolytic anemia, thrombocytopenia, and microvascular occlusion secondary to acquired ADAMTS13 deficiency...

DOI: 10.1002/jca.70017
Jacobs JW, Adkins BD, Booth GS, Stanek CG, Allen ES, Grossman BJ, Stephens LD, Crowe EP, Daou L, Marques MB, Siniard RC, Wallace LR, Yamada C, Duque MA, Wu Y, Aljuboori O, Harrington TJ, Byrnes DM, Eichbaum Q, Figueroa Villalba CA, Juskewitch JE, Kla
Journal of clinical apheresis, 2025-04-03